Hrt Financial »

Kalaris Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $67k 12k 5.77

More positions owned by Hrt Financial

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Put
Microsoft Corp Call
Sandisk Corp (SNDK)
Nvidia Corporation Call
Nvidia Corporation Put
Apple Call
Amazon Call
Wal-Mart Stores (WMT)
Apple (AAPL)
Meta Platforms Call
Marvell Technology (MRVL)
Ishares Tr Put

View all positions for Hrt Financial

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Alyeska Investment Group
Siren
Ikarian Capital
Propel Bio Management
Vanguard Group
Vanguard Capital Management
Kalehua Capital Management
Goldman Sachs Group
Woodline Partners
ADAR1 Capital Management
Whi Trust
Boothbay Fund Management

View all funds holding Kalaris Therapeutics